These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17052065)

  • 21. Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F
    Transfus Clin Biol; 2012 Jun; 19(3):132-8. PubMed ID: 22818360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Delayed hemolytic reaction to transfusion in sickle cell anemia. Report of one case].
    Moya F; Rivera M; Araya F; Donoso J; Sandoval P; Varas P
    Rev Med Chil; 2018 Nov; 146(11):1347-1350. PubMed ID: 30725050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal septic shock associated with transfusion-transmitted Serratia marcescens.
    Ramírez-Arcos S; Chin-Yee I; Hume H; Fearon M; Goldman M; Eckert K; Martincic I; Peters G; Kovach D; Richardson SE
    Transfusion; 2006 Apr; 46(4):679-81. PubMed ID: 16584449
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevention of delayed hemolytic transfusion reaction.
    Pirenne F
    Transfus Clin Biol; 2019 May; 26(2):99-101. PubMed ID: 30926306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A delayed hemolytic transfusion reaction due to anti-Cob.
    Squires JE; Larison PJ; Charles WT; Milner PF
    Transfusion; 1985; 25(2):137-9. PubMed ID: 3984006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM; Miller MJ; Chonat S; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.
    Blauel ER; Grossmann LT; Vissa M; Miller ST
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e438-40. PubMed ID: 26207780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current issues with blood transfusions in sickle cell disease.
    Vichinsky EP
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):14-22. PubMed ID: 11206956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe Acute Infection Due to Serratia marcescens Causing Respiratory Distress in An Immunocompetent Adult.
    Ruiz-Sada P; Escalante M; Lizarralde E
    Rom J Intern Med; 2016; 54(2):134-6. PubMed ID: 27352443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute epiglottitis due to Serratia marcescens in an immunocompetent adult.
    Musham CK; Jarathi A; Agarwal A
    Am J Med Sci; 2012 Aug; 344(2):153-4. PubMed ID: 22543595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Vidler JB; Gardner K; Amenyah K; Mijovic A; Thein SL
    Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion-transmitted babesiosis leading to severe hemolysis in two patients with sickle cell anemia.
    Karkoska K; Louie J; Appiah-Kubi AO; Wolfe L; Rubin L; Rajan S; Aygun B
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases.
    Santos B; Portugal R; Nogueira C; Loureiro M
    Transfusion; 2015 Jun; 55(6 Pt 2):1394-8. PubMed ID: 25677578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient.
    Delmonte L; Cantini M; Olivieri O; De Franceschi L
    Transfusion; 2013 Mar; 53(3):688-9. PubMed ID: 23473065
    [No Abstract]   [Full Text] [Related]  

  • 35. Serratia marcescens contamination of feline whole blood in a hospital blood bank.
    Hohenhaus AE; Drusin LM; Garvey MS
    J Am Vet Med Assoc; 1997 Mar; 210(6):794-8. PubMed ID: 9074682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Infection with Serratia marcescens in newborn infants. Clinical aspects, therapy and disease course].
    Scharf JW; Wild F; Guggenbichler JP
    Monatsschr Kinderheilkd; 1991 Oct; 139(10):695-8. PubMed ID: 1961210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risks associated with transfusions in sickle cell disease: delayed hemolytic transfusion reaction].
    Habibi A; Noizat-Pirenne F
    Rev Prat; 2014 Oct; 64(8):1128-9. PubMed ID: 25510142
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen.
    Larson PJ; Lukas MB; Friedman DF; Manno CS
    Am J Hematol; 1996 Dec; 53(4):248-50. PubMed ID: 8948664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial complications of Serratia marcescens infection in neonates.
    Madide A; Smith J
    S Afr Med J; 2016 Mar; 106(4):36-8. PubMed ID: 27032843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.